Showing 1030 – 1040 of 1159 results
-
Denali Therapeutics Inc Initiation
William Blair initiated research coverage of Denali Therapeutics Inc. (DNLI $20.38), a clinical-stage biotechnology company developing treatments for CNS and other indications by leveraging its unique blood–brain barrier penetrating technology platform.
-
Elevation Oncology Inc Initiation
William Blair initiated research coverage of Elevation Oncology, Inc. (ELEV $0.56), a clinical-stage biotechnology company advancing a Phase I antibody-drug conjugate (ADC) against claudin 18.2, initially targeting gastric cancer/gastroesophageal junction (GEJ) adenocarcinoma with pancreatic cancer as an expansion opportunity.
-
Cardiff Oncology Inc Initiation
William Blair initiated research coverage of Cardiff Oncology, Inc. (CRDF $6.43), a clinical-stage biotechnology company that leverages deep insights into synthetic lethality through PLK1 inhibition in cancers. The company is advancing three clinical programs in parallel in colorectal, prostate, and pancreatic cancer.
-
ARS Pharmaceuticals Inc Initiation
William Blair initiated research coverage of ARS Pharmaceuticals, Inc. (SPRY $8.50), a clinical-stage biopharmaceutical company focused on developing treatments that are safe, effective, needle-free, easy to carry, and simple to administer for people affected by severe allergic reactions.
-
NAPCO Security Technologies Inc Initiation
William Blair initiated research coverage of NAPCO Security Technologies, Inc. (NSSC $32.46), a provider of commercial and residential intrusion, fire, access control, and door locking hardware and services.
-
Mesoblast Limited Initiation
William Blair initiated research coverage of Mesoblast Limited (MESO $3.03). Mesoblast is an Australia-based biotechnology company focused on the development of allogeneic mesenchymal lineage cells for the treatment of severe and life-threatening inflammatory diseases.
-
William Blair Initiates Coverage of Four Companies in the Lithium-Ion Battery Industry
William Blair initiated research coverage of Enovix Corporation, Amprius Technologies, Inc., SES AI Corporation, and QuantumScape Corporation.
-
OneStream Inc Initiation
William Blair initiated research coverage of OneStream, Inc. (OS $28.27), a fast-growing software platform modernizing the office of the CFO.
-
ON24, Inc. Initiation
William Blair & Company initiated research coverage of ON24, Inc. (ONTF $55.26). ON24 is a digital experience platform that enables businesses to run interactive webinars and virtual event experiences with a focus on driving customer engagement and converting revenue.
-
908 Devices Inc Initiation
William Blair & Company initiated research coverage of 908 Devices Inc. (MASS $52.91). Boston-based 908 Devices delivers high-quality mass spectrometry to a broad set of users at the point of need. The company does this through an innovative suite of purpose-built handheld and desktop mass spectrometry devices that are smaller and more accessible than conventional lab instruments.